The #1 preferred glucose sensor by Canadian endocrinologists†,1 is now the most covered CGM on government funded programs in Ontario for people on insulin.*,2
Complete the form below to request a Dexcom G7 sample.
Dexcom G7 is easy to use and prescribe
It’s covered by RAMQ and most private insurers for patients on insulin in Quebec. Write a prescription and your patient is set, no prior approval or forms are needed through RAMQ.
Prescribe the right CGM for your patients
The most accurate CGM with clinically proven outcomes‡,2
Clinically proven to lower A1C, reduce hypoglycemic events, increase time in range, and improve glycemic outcomes.3-7
Alerts that support safer insulin therapy
The predictive "Urgent Low Soon" alert can warn patients in advance of severe hypoglycemia§, plus the Delay 1st High alert after a meal may help reduce insulin stacking.8,9
Unparalleled convenience for any lifestyle
The only waterproof CGM¶ that has the fastest warm-up time, multiple wear locations# and display devices.
* For full coverage criteria, please visit our Quebec Public Coverage page.
† Based on a survey of Canadian Endocrinologists (n=41)
‡ When compared with CGM systems commercially available in Canada as of July 2025. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen.
§ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes. For more information, review the Dexcom G7 User Guide.
¶ The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
# Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old.
** Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024
2 Dexcom data on file, 2025
3 Beck, RW, et al. JAMA. 2017;317(4):371-378.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Martens T, et al. JAMA. 2021;325(22):2262-2272.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
8 Aly A, et al. Diabetes Technol. Ther. 2024;26(S2): A254-255.
9 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.